Literature DB >> 765025

Dynamics of thymidine incorporation by spleen cells from rats infected with Plasmodium berghei.

J Golenser, D T Spira, A Zuckerman.   

Abstract

The in vitro incorporation of thymidine by spleen cells of rat infected with Plasmodium berghei was higher than that of normal rat spleen cells. The incorporation was proportional to the number of cells in the system and was related to the day of infection, e.g. spleen cells from malarious rats incorporated up to forty times as much thymidine as did normal spleen cells 21 days after inoculation. At the same time, the response of the malarious spleen cells to phytohaemagglutinin (PHA) was only one-twentieth of that observed for normal spleen cells. The thymidine was incorporated by non-adherent spleen cells in a single pulse during the first 8 hr in culture.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 765025      PMCID: PMC1538280     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  12 in total

1.  MALARIA ANTIBODY CONTENT OF GAMMA 2-7S GLOBULIN IN TROPICAL POPULATIONS.

Authors:  C C CURTAIN; C KIDSON; D L CHAMPNESS; J G GORMAN
Journal:  Nature       Date:  1964-09-26       Impact factor: 49.962

2.  Blood loss and replacement in plasmodial infections. I. Plasmodium berghei in untreated rats of varying age and in adult rats with erythropoietic mechanisms manipulated before inoculation.

Authors:  A ZUCKERMAN
Journal:  J Infect Dis       Date:  1957 Mar-Apr       Impact factor: 5.226

3.  Anaemia and erythropoiesis in the irradiated rat: an experimental study with particular reference to techniques involving radioactive iron.

Authors:  C F BAXTER; E H BELCHER; E B HARRISS; L F LAMERTON
Journal:  Br J Haematol       Date:  1955-01       Impact factor: 6.998

4.  The cellular reactions to infections with Plasmodium berghei in the white mouse.

Authors:  I SINGER
Journal:  J Infect Dis       Date:  1954 May-Jun       Impact factor: 5.226

5.  Biological effects of the adjuvant Corynebacterium parvum. I. Inhibition of PHA, mixed lymphocyte and GVH reactivity.

Authors:  M T Scott
Journal:  Cell Immunol       Date:  1972-11       Impact factor: 4.868

6.  Possible role of a B-cell mitogen in hypergammaglobulinaemia in malaria and trypanosomiasis.

Authors:  B M Greenwood
Journal:  Lancet       Date:  1974-03-16       Impact factor: 79.321

7.  Immunosuppression in murine malaria. I. General characteristics.

Authors:  B M Greenwood; J H Playfair; G Torrigiani
Journal:  Clin Exp Immunol       Date:  1971-03       Impact factor: 4.330

8.  On the mode of action of BCG.

Authors:  M S Mitchell; D Kirkpatrick; M B Mokyr; I Gery
Journal:  Nat New Biol       Date:  1973-06-13

9.  Plasmodium berghei: passive transfer of immunity by antisera and cells.

Authors:  R S Phillips
Journal:  Exp Parasitol       Date:  1970-06       Impact factor: 2.011

10.  PHA-induced lymphocyte transformations in leucocyte cultures from malarious, malnourished and control Gambian children.

Authors:  D L Moore; B Heyworth; J Brown
Journal:  Clin Exp Immunol       Date:  1974-08       Impact factor: 4.330

View more
  4 in total

1.  Suppressor cells and loss of B-cell potential in mice infected with Trypanosoma brucei.

Authors:  A C Corsini; C Clayton; B A Askonas; B M Ogilvie
Journal:  Clin Exp Immunol       Date:  1977-07       Impact factor: 4.330

2.  The reactivity of spleen cells from malarious rats to non-specific mitogens.

Authors:  D T Spira; J Golenser; I Gery
Journal:  Clin Exp Immunol       Date:  1976-04       Impact factor: 4.330

3.  Specific lymphocyte transformation in murine malaria.

Authors:  J Golenser; D T Spira; J P Verhave; J H Meuwissen
Journal:  Z Parasitenkd       Date:  1976-07-27

4.  Immune depression in trypanosome-infected mice. IV. Kinetics of suppression and alleviation by the trypanocidal drug Berenil.

Authors:  G E Roelants; T W Pearson; W I Morrison; K S Mayor-Withey; L B Lundin
Journal:  Clin Exp Immunol       Date:  1979-09       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.